Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

PaperCitations, authors & open-access status

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 932 citations, 2018 year and closed oa status.

932
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Diego Centonze
Author
Caroline Papeix
Author
The Lancet
Journal
Multiple Sclerosis Research Studies
Topic
Multiple Sclerosis Research Studies
Topic
Sphingolipid Metabolism and Signaling
Topic
470M+ articles · free account